ArticleOncoimmunology2021

PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer.

Mohanad H Nada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.